Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma

Published:2020-02-19 Issue:7 Volume:24 Page:4150-4156
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Hu Minjuan¹,Zhang Yanwei¹,Sun Beibei²,Lou Yuqing¹,Zhang Xueyan¹,Wang Huimin¹,Huang Chengya³,Zhang Wei¹,Chu Tianqing¹,Han Baohui¹^ORCID

Affiliation:

1. Department of Pulmonary Medicine Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

2. Department of Central Laboratory Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

3. Department of Anesthesiology Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15071

Reference29 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement

3. Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening

4. Lung cancer screening: latest developments and unanswered questions

5. Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP